Metabotropic glutamate receptor 5
Metabotropic glutamate receptor 5 (mGluR5) is a type of G protein-coupled receptor (GPCR) that is activated by the neurotransmitter glutamate. It is part of the metabotropic glutamate receptor family, which plays a crucial role in the modulation of synaptic transmission and neuronal excitability.
Structure[edit | edit source]
mGluR5 is a large protein composed of 1212 amino acids. It has a seven-transmembrane domain structure, characteristic of GPCRs, with an extracellular N-terminus and an intracellular C-terminus. The N-terminus contains the glutamate binding site, while the C-terminus is involved in intracellular signaling pathways.
Function[edit | edit source]
mGluR5 receptors are primarily found in the central nervous system, including the cerebral cortex, hippocampus, and basal ganglia, where they regulate a variety of physiological processes. They modulate synaptic plasticity, a key process in learning and memory, and are involved in the regulation of neuronal excitability. mGluR5 receptors also play a role in neurodevelopment and have been implicated in several neurological and psychiatric disorders.
Clinical significance[edit | edit source]
Alterations in mGluR5 function have been associated with a range of neurological and psychiatric disorders, including schizophrenia, depression, anxiety disorders, and fragile X syndrome. mGluR5 antagonists have shown promise in preclinical and clinical trials for these disorders. Additionally, mGluR5 has been implicated in drug addiction, with mGluR5 antagonists reducing drug-seeking behavior in animal models.
Pharmacology[edit | edit source]
Several drugs that target mGluR5 have been developed for therapeutic use. These include both agonists, which activate the receptor, and antagonists, which block its activity. mGluR5 antagonists have been investigated for their potential use in treating conditions such as Parkinson's disease, chronic pain, and anxiety disorders.
See also[edit | edit source]
This GPCR-related article is a stub. You can help WikiMD by expanding it.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
